Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction

Voiding dysfunction due to detrusor underactivity or urethral sphincter dysfunction is a treatment challenge for urologists. Recently, urologists have used botulinum toxin A (BoNT-A) injection into the urethral sphincter to treat voiding dysfunction. This treatment has been found to decrease urethra...

Descripción completa

Detalles Bibliográficos
Autor principal: Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442911/
https://www.ncbi.nlm.nih.gov/pubmed/28757732
http://dx.doi.org/10.1016/j.tcmj.2016.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442911/
https://www.ncbi.nlm.nih.gov/pubmed/28757732
http://dx.doi.org/10.1016/j.tcmj.2016.07.001

Ejemplares similares